Highlights J o u r n a l P r e -p r o o f  MERS is an emerging infectious disease of high consequences.  PHE Manchester receives a high number of MERS surveillance samples  Sputum samples are the optimum samples for diagnosing respiratory viruses  Multiple samples per patient result in a 100% diagnostic yield and a confirmed end-diagnosis Abstract-199 words Background Middle East Respiratory Syndrome Coronavirus (MERS-CoV) emerged in Saudi Arabia in 2012 and caused an epidemic in the Middle East. Public Health England (PHE) Manchester is one of the two PHE centres in the UK that perform testing for MERS-CoV. The results of the PHE Manchester MERS surveillance from 2012 to 2019 are presented in this report.
Introduction
A novel coronavirus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) emerged in Saudi Arabia in 2012. The first case was a Saudi national admitted in June 2012 with pneumonia and renal failure which resulted in a fatal outcome. The case was later identified in September 2012 as a novel betacoronavirus belonging to lineage C (4) . Retrospective testing of samples in the Middle East identified a further nine cases in Jordan (5) . The disease was considered a clinical syndrome ranging from asymptomatic cases to respiratory failure to multisystem organ failure. The syndrome was termed "Middle Eastern Respiratory Syndrome" (MERS) and testing was performed accordingly in the Middle East and for return travellers from Middle East countries based on epidemiological risk factors.
J o u r n a l P r e -p r o o f
The second global case of MERS was identified in a Qatari national who had previously travelled to Saudi Arabia in 2012. He was transferred from Qatar to a hospital in England where he clinically deteriorated, was placed on extracorporeal membrane oxygenation (ECMO) however, unfortunately had a fatal outcome (6) . A second case in the UK was confirmed in February 2013, in a return traveler from Pakistan and Saudi Arabia who was admitted with severe acute respiratory symptoms. This patient required ECMO treatment however also unfortunately died. This case resulted in onward transmission to two further cases, of which one subsequently died (7) . In August 2018, a fifth case of MERS was diagnosed in a return traveler from the Middle East. The patient was initially admitted to a hospital in Leeds and then transferred to specialist infectious disease unit in Liverpool. The patient had a positive outcome and there was no onward transmission of MERS-CoV to the close contacts (8) As of the end of November 2019, MERS Co-V has infected 2,494 people with a case fatality rate (CFR) of 37.1% (9, 10) and a notably higher CFR in ITU settings (11) . Nosocomial outbreaks have occurred in Saudi Arabia and South Korea demonstrating the need for stringent infection control polices (12) . In view of the high risk of imported cases, Public Health England (PHE) commissioned regional centers to perform MERS-CoV testing for possible MERS cases arriving in England. PHE Manchester laboratory is one of two centers that currently perform testing for MERS-CoV . It receives samples from the Greater Manchester region and surrounding counties of Lancashire, Merseyside, Cumbria and Cheshire. Additionally it receives samples from other areas of the North-West region of the United Kingdom which entails the counties of Yorkshire, Humber and also the counties of the North-East region.
The Greater Manchester (GM) region has a population of around 2.5 million people with a black and minority ethnic population of 33.4% (13) ; some of whom are more likely to travel to J o u r n a l P r e -p r o o f the Middle East for visiting friends or family, business, religious pilgrimage or tourism. The GM region also has a Muslim population of 15.8% (1, 14) which is greater than the national average in the United Kingdom of 5% (1). The Muslim population will visit the Kingdom of Saudi Acute respiratory illness (ARI) and contact with a confirmed case of MERS-CoV in the 14 days prior to onset.
Methods

Data Collection of Patients
Those meeting the PHE case definition were discussed with the Regional Infectious Diseases team and/or the Consultant Virologist and then tested for infection (3) ( Figure 1 ).
The majority of cases were initially discussed with the RIDU team and then transferred to 
MERS-CoV & Respiratory Virus Testing
Results
Samples
Four hundred and twenty-six samples (426) were received for two hundred and sixty-four England with the majority sent from the regional infectious disease unit and from university teaching hospitals (Supplementary figures 1 & 2) .
Patient Demographics
Patient's age ranged from 18 weeks to 89 years old. Patient demographic characteristics are shown in Table 2 .
Fifty-five percent of patients were of Asian background with 23% & 19% of Arab & Caucasian backgrounds, respectively (Supplementary figure 3) .
Travel History
The travel history as noted on the LIMS system and request forms showed the majority of (Supplementary figure 13) .
Peak Testing for MERS-CoV
J o u r n a l P r e -p r o o f
The dates for Hajj, Umrah and Ramadan fluctuates every year as the Islamic calendar is lunar based thus the dates usually change by 10 days annually ( Figure 7) .
When analysing the sample type, of note is that the highest positivity is of sputum samples, followed by BAL. However, the lowest positivity of samples is of nasopharyngeal aspirates (NPA) however the number of samples was low for this to be considered significant as only one NPA sample was received. 
It is likely there will be more testing after these periods especially as travellers might also be returning via the Middle East after the summer vacation months. Similarly the peak testing is September and June in 2018 correlating post Hajj (19th-24th August 2018) and Ramadan (16th May to 14th June 2018). Combined with the UK school vacation periods this resulted in more returning travellers causing a higher testing rate after these periods.
As the clinical spectrum of MERS is broad, there is the possibility that some cases may be missed in asymptomatic patients, who do not fit the PHE criteria and those patients who do not attend hospital. However, the risk of transmission from asymptomatic cases is considered lower than symptomatic cases thus there is less of a need to focus on these patients from a public health perspective (20) . Furthermore, attempting to screen every traveller returning from a 
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